Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "f hoffmann la roche ltd"

Roche announces encouraging results from Phase II breast cance...

F. Hoffmann-La Roche Ltd has announced encouraging results from the Phase II Neoadjuvant Study of Pertuzumab and Herceptin in an Early Regimen Evaluation, or NeoSphere, study for Perjeta in patients with HER2-positive early breast cancer, or eBC., 2 weeks ago

8 images for f hoffmann la roche ltd

Global Information Inc, 2 weeks ago
National Public Relations Inc., 1 month ago
KXXV-TV, 1 day ago
Sys-Con Media, 1 day ago
I Stock Analyst, 2 months ago, 3 months ago
KXXV-TV, 3 months ago
Mubasher, 5 months ago

Roche receives CLIA waiver for Strep A detection assay from FDA

F. Hoffmann-La Roche Ltd has received the FDA Clinical Laboratory Improvement Amendments, or CLIA, waiver for the cobas Strep A test for use on the cobas Liat system. It is the first CLIA-waived PCR test to detect Strep A in throat swab specimens in ...
 Individual.com1 month ago Roche receives FDA clearance for herpes simplex virus detection test  Individual.com2 weeks ago Roche receives FDA clearance for C. difficile detection test  Individual.com2 weeks ago

Roche announces encouraging follow-up data from two melanoma studies

F. Hoffmann-La Roche Ltd has announced encouraging follow-up data from two studies of the investigational MEK inhibitor, cobimetinib, in combination with Zelboraf in patients with advanced melanoma. Updated data from the pivotal coBRIM Phase III ...
 Individual.com2 weeks ago

Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review

Eli Lilly and Company F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc Sanofi-Aventis provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by The publisher to bring to you a ...
 Research and Markets1 week ago

Global Insulin Pumps Market 2014-2018

FEATURED COMPANIES and Medtronic Inc. Animas Corp. F. Hoffmann La Roche Ltd. Insulet Corp. MORE The analysts forecast the Global Insulin Pumps market to grow at a CAGR of ...
 Research and Markets2 weeks ago Global Insulin Pumps market to grow at a CAGR of 7.78 percent over the period 2013-2018  Market Pulse Navigator2 weeks ago
Global Information Inc

Investigation Report on China Capecitabine Market, 2010-2019

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China ...
 Global Information Inc2 weeks ago

Roche Diagnostics International Ltd - Product Pipeline Analysis, 2015

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on Roche Diagnostics International Ltd. (Roche Diagnostics) offers novel diagnostic tests and systems ...
 Industrial Info Financials4 days ago

Findings in the Area of Pharmacology Reported from F. Hoffmann-La Roche (Quantifying the impact of transporters on cellular drug permeability)

By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Drugs and Therapies. According to news reporting originating in Basel, Switzerland , by NewsRx journalists, research stated, "The conventional model of drug ...
 4 Traders3 weeks ago

Global Osteoporosis Drugs Market Will Reach US $14.8 Billion by 2022 : Persistence Market Research

Source: Persistence Market Research Pvt. Ltd According to a new market report published by Persistence Market Research Global Market Study on Osteoporosis Drugs: Asia Pacific to Witness Highest Growth by 2022, the global osteoporosis drugs market ...
 Pharma Voice4 days ago Global Osteoporosis Drugs Market Worth US$14.8 Billion by 2022, by Persistence Market Research  BizWire Express3 days ago Global Osteoporosis Drugs Market Projected to Reach US$ 14.78 Bn by 2022: Persistence Market Research  MoneyShow.com1 week ago

ROCHE BEARER SHARE : Atnahs Pharma Acquires Naprosyn, Anaprox and Toradol from Roche

Deal Type: Asset Transaction Deal Country: Switzerland Deal Status: Completed Deal Value: 0.0000 USD Deal in Brief Atnahs Pharma UK Limited , a pharmaceutical company, has acquired Naprosyn, Anaprox and Toradol from F. Hoffmann-La Roche Ltd. ( ...
 4 Traders5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - f hoffmann la roche ltd
Get updated on latest news & your favorite topics right in your inbox!
More     Less